Austin-based robotic automation company Diligent Robotics has closed over US$30m (£23m) in Series B funding, to further develop its socially-intelligent service robots and AI solutions that enable robots to collaborate within and adapt to human environments.
The company’s flagship product, Moxi, is a robot that performs delivery tasks for frontline healthcare teams. The collaborative robot assistant helps clinical staff with routine, not-patient-facing tasks including fetching and delivering supplies, medications, or lab samples. It has been developed to assist with labour shortages.
This latest funding was led by Tiger Global, it brings the total investment raised to date to nearly US$50m (£38m). Diligent also maintains the support of existing investors, including True Ventures, DNX Venture, Ubiquity Ventures, E14 Fund, Next Coast Ventures, Boom Capital, Gaingels as well as additional commitments from new investors including Cedars-Sinai Health Ventures.
“We are proud to have the full support of our past investors and welcome our new partners who joined during our Series B raise,” said Dr. Andrea Thomaz, co-founder of Diligent Robotics.
“This new round of funding will help us scale the company to meet the incredible demand for our healthcare service robot. Thanks to the support of our investors and the Diligent team, we are focused on expanding automated support for clinical teams so nurses and clinicians can focus on tasks that matter most, patient care.”
